Get the Stockscreener App
0.4927
1.21%
0.0059
Talphera Inc stock is traded at $0.4927, with a volume of 275.57K.
It is up +1.21% in the last 24 hours and up +23.18% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$0.4868
Open:
$0.4722
24h Volume:
275.57K
Relative Volume:
0.22
Market Cap:
$10.10M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-0.5796
EPS:
-0.85
Net Cash Flow:
$-15.13M
1W Performance:
+15.83%
1M Performance:
+23.18%
6M Performance:
-17.95%
1Y Performance:
-45.26%
1-Day Range:
$0.4654
$0.5157
1-Week Range:
$0.3974
$0.66
52-Week Range:
$0.38
$1.19
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.4927 | 8.87M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Talphera Beats Investors' Bid To Save Slogan Suit At 9th Circ. - Law360
Should you wait for a breakout in Talphera Inc.Earnings Performance Report & Accurate Buy Signal Notifications - Newser
Talphera Investors Lose Bid to Reopen ‘Tongue and Done’ Suit (1) - Bloomberg Law News
Published on: 2025-08-21 01:58:53 - kangso.co.kr
Will Talphera Inc. bounce back from current supportJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Understanding Talphera Inc.’s price movementInsider Selling & Free Daily Entry Point Trade Alerts - Newser
What machine learning models say about Talphera Inc.Insider Selling & Intraday High Probability Alerts - Newser
Combining price and volume data for Talphera Inc.Stock Surge & Free Safe Entry Trade Signal Reports - Newser
Detecting price anomalies in Talphera Inc. with AIWall Street Watch & Reliable Intraday Trade Alerts - Newser
Technical signs of recovery in Talphera Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Talphera (TLPH.O) Surges 10.6% on Strong Sell Signal and Mixed Sector Activity - AInvest
Measuring Talphera Inc.’s beta against major indicesJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - Newser
Will Talphera Inc. see short term momentumJuly 2025 Short Interest & Long-Term Growth Plans - Newser
Is This the Dip to Buy in Talphera Inc.2025 Market Overview & AI Forecasted Entry and Exit Points - classian.co.kr
Is it too late to sell Talphera Inc.Analyst Downgrade & Weekly Watchlist for Hot Stocks - Newser
How does Talphera Inc. compare to its peersMarket Movers & Step-by-Step Swing Trade Plans - thegnnews.com
Analyzing Talphera Inc. with risk reward ratio chartsEarnings Growth Report & Reliable Volume Spike Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Talphera Inc.July 2025 Rallies & Real-Time Volume Spike Alerts - Newser
How to recover losses in Talphera Inc. stock2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
Talphera Inc. recovery potential after sell offWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Talphera Inc. stock outlook for YEARJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser
Trend analysis for Talphera Inc. this week2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Order flow analysis tools used on Talphera Inc.Portfolio Return Report & Fast Gain Stock Trading Tips - Newser
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position - TipRanks
Talphera, Inc. (NASDAQ:TLPH) Sees Significant Decrease in Short Interest - Defense World
How to read the order book for Talphera Inc.July 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Talphera Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTrade Analysis Report & Verified Swing Trading Watchlists - Newser
Intraday pattern recognizer results for Talphera Inc.Weekly Trade Report & Weekly Breakout Watchlists - Newser
Full technical analysis of Talphera Inc. stockBond Market & AI Based Buy/Sell Signal Reports - Newser
Talphera outlines accelerated NEPHRO enrollment and lowers 2025 cash operating expense guidance amid protocol shift - MSN
Talphera Reports Q2 2025 Financial Results and Study Progress - TipRanks
Talphera: Q2 Earnings Snapshot - Norwalk Hour
Talphera Inc (TLPH) Q2 2025 Earnings Call Highlights: Strategic Adjustments and Enrollment ... - Yahoo Finance
How high can Talphera Inc. stock price go in 2025Sell Signal & Reliable Price Action Trade Plans - Newser
Talphera (TLPH) and the Nafamostat Trial Progress: A Turnaround Story in the Anticoagulant-CRRT Niche - AInvest
Talphera's Strategic Turnaround: A Catalyst for Undervalued Biotech Investment - AInvest
Transcript : Talphera, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Talphera Inc Stock (TLPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Dec 05 '24 |
Buy |
0.64 |
5,000 |
3,200 |
208,066 |
| ASADORIAN RAFFI | Chief Financial Officer |
Dec 02 '24 |
Sale |
0.77 |
155 |
119 |
37,578 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Nov 27 '24 |
Buy |
0.73 |
5,000 |
3,650 |
203,066 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):